Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases

被引:36
作者
Kobayashi, Atsushi [1 ]
Kaido, Toshimi [1 ]
Hamaguchi, Yuhei [1 ]
Okumura, Shinya [1 ]
Shirai, Hisaya [1 ]
Kamo, Naoko [1 ]
Yagi, Shintaro [1 ]
Taura, Kojiro [1 ]
Okajima, Hideaki [1 ]
Uemoto, Shinji [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Div Hepatobiliary Pancreat & Transplant Surg, Dept Surg,Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan
关键词
SKELETAL-MUSCLE; EICOSAPENTAENOIC ACID; HEPATIC RESECTION; PROGNOSTIC-FACTOR; TISSUE CONTENT; MASS INDEX; CANCER; SURVIVAL; HEPATECTOMY; MANAGEMENT;
D O I
10.1007/s00268-017-4255-5
中图分类号
R61 [外科手术学];
学科分类号
摘要
We have reported preoperative low skeletal muscularity as an independent risk factor for poor outcomes after liver transplantation, resection of hepatocellular carcinoma, pancreatic cancer and extrahepatic biliary malignancies. However, the impacts of visceral adiposity and muscularity on outcomes after liver resection for colorectal liver metastases (CLM) have not been fully investigated. We retrospectively analyzed 124 patients undergoing primary liver resection for CLM between 2005 and 2014. Using preoperative computed tomography at the third lumbar vertebra level, skeletal muscle and abdominal adipose tissue were evaluated by skeletal muscle index (SMI), intramuscular adipose tissue content (IMAC) and visceral-to-subcutaneous adipose tissue area ratio (VSR), respectively. Impacts of preoperative SMI, IMAC and VSR on outcomes after liver resection for CLM were investigated. Low SMI and high VSR were not significantly associated with poor overall or recurrence-free survivals (P = 0.324 and P = 0.106, P = 0.964 and P = 0.738, respectively). Overall survival rate tended to be lower in patients with high IMAC than in patients with normal IMAC (P = 0.054). Recurrence-free survival rate did not differ significantly between high and normal IMAC (P = 0.721). Multivariate analysis showed that low SMI, high IMAC and high VSR were not significant risk factors for death or recurrence after liver resection for CLM. Neither preoperative visceral adiposity nor low muscularity were poor prognostic factors in patients undergoing liver resection for CLM.
引用
收藏
页码:1180 / 1191
页数:12
相关论文
共 42 条
  • [1] Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition
    Bahat, Gulistan
    Tufan, Asli
    Tufan, Fatih
    Kilic, Cihan
    Akpinar, Timur Selcuk
    Kose, Murat
    Erten, Nilgun
    Karan, Mehmet Akif
    Cruz-Jentoft, Alfonso J.
    [J]. CLINICAL NUTRITION, 2016, 35 (06) : 1557 - 1563
  • [2] Chemotherapy and Targeted Therapy for Patients with Initially Unresectable Colorectal Liver Metastases, Focusing on Conversion Hepatectomy and Long-Term Survival
    Beppu, Toru
    Miyamoto, Yuji
    Sakamoto, Yasuo
    Imai, Katsunori
    Nitta, Hidetoshi
    Hayashi, Hiromitsu
    Chikamoto, Akira
    Watanabe, Masayuki
    Ishiko, Takatoshi
    Baba, Hideo
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : 405 - 413
  • [3] Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort
    Bijlsma, A. Y.
    Meskers, C. G. M.
    Ling, C. H. Y.
    Narici, M.
    Kurrle, S. E.
    Cameron, I. D.
    Westendorp, R. G. J.
    Maier, A. B.
    [J]. AGE, 2013, 35 (03) : 871 - 881
  • [4] Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy
    Bismuth, H
    Adam, R
    Levi, F
    Farabos, C
    Waechter, F
    Castaing, D
    Majno, P
    Engerran, L
    [J]. ANNALS OF SURGERY, 1996, 224 (04) : 509 - 520
  • [5] Sarcopenia: Current Concepts and Imaging Implications
    Boutin, Robert D.
    Yao, Lawrence
    Canter, Robert J.
    Lenchik, Leon
    [J]. AMERICAN JOURNAL OF ROENTGENOLOGY, 2015, 205 (03) : W255 - W266
  • [6] Sarcopenia: European consensus on definition and diagnosis
    Cruz-Jentoft, Alfonso J.
    Baeyens, Jean Pierre
    Bauer, Juergen M.
    Boirie, Yves
    Cederholm, Tommy
    Landi, Francesco
    Martin, Finbarr C.
    Michel, Jean-Pierre
    Rolland, Yves
    Schneider, Stephane M.
    Topinkova, Eva
    Vandewoude, Maurits
    Zamboni, Mauro
    [J]. AGE AND AGEING, 2010, 39 (04) : 412 - 423
  • [7] Rates and Patterns of Recurrence Following Curative Intent Surgery for Colorectal Liver Metastasis An International Multi-Institutional Analysis of 1669 Patients
    de Jong, Mechteld C.
    Pulitano, Carlo
    Ribero, Dario
    Strub, Jennifer
    Mentha, Gilles
    Schulick, Richard D.
    Choti, Michael A.
    Aldrighetti, Luca
    Capussotti, Lorenzo
    Pawlik, Timothy M.
    [J]. ANNALS OF SURGERY, 2009, 250 (03) : 440 - 448
  • [8] The impact of neoadjuvant chemotherapy on skeletal muscle depletion and preoperative sarcopenia in patients with resectable colorectal liver metastases
    Eriksson, Sam
    Nilsson, Jan H.
    Holka, Peter Strandberg
    Eberhard, Jakob
    Keussen, Inger
    Sturesson, Christian
    [J]. HPB, 2017, 19 (04) : 331 - 337
  • [9] Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)
    Folprecht, G.
    Gruenberger, T.
    Bechstein, W.
    Raab, H. -R.
    Weitz, J.
    Lordick, F.
    Hartmann, J. T.
    Stoehlmacher-Williams, J.
    Lang, H.
    Trarbach, T.
    Liersch, T.
    Ockert, D.
    Jaeger, D.
    Steger, U.
    Suedhoff, T.
    Rentsch, A.
    Koehne, C. -H.
    [J]. ANNALS OF ONCOLOGY, 2014, 25 (05) : 1018 - 1025
  • [10] Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
    Folprecht, Gunnar
    Gruenberger, Thomas
    Bechstein, Wolf O.
    Raab, Hans-Rudolf
    Lordick, Florian
    Hartmann, Joerg T.
    Lang, Hauke
    Frilling, Andrea
    Stoehlmacher, Jan
    Weitz, Juergen
    Konopke, Ralf
    Stroszczynski, Christian
    Liersch, Torsten
    Ockert, Detlev
    Herrmann, Thomas
    Goekkurt, Eray
    Parisi, Fabio
    Koehne, Claus-Henning
    [J]. LANCET ONCOLOGY, 2010, 11 (01) : 38 - 47